Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Flooring Hut is a UK-based technology company that aims to disrupt the UK flooring industry valued at £2bn in 2017. Touted as the smarter way to buy new carpets & flooring, Flooring Hut has made 24,000+ online sales across domestic and trade sectors by building a huge network of independent installers. The company's USP is to connect a disjointed market and allow customers access to value products, samples, leading brands and a suitable, vetted local installer to perform the work. The key to its success to date has been a consistent and reliable mix of pricing, availability, and selection. Till date, the company has 786 registered trade customers, 140+ Flooring Hut Installer Network of members, and 12,000 products available for sale. With the proceeds, the company will develop its self-service platform functionality for customers and expand its reach on social media and affiliate marketing.
days to go:
Expired
investment:
£57,077
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.
days to go:
Expired
investment:
£908,950
RoosterMoney is a pocket money application & debit card that aims to transform the way kids learn about money around the globe. It has more than 200,000 monthly active users. The company launched a Visa prepaid debit card in the UK, in July 2019, with over 16,000 card users. RoosterMoney has featured in publications like the Guardian, The Times, and the BBC. Its 'Pocket Money Index' has been quoted on CNBC, The Wall Street Journal (USA), and the Sydney Herald (Australia). The company will use 30% of the investment in marketing, 40% in team and product development, and 30% in upgrading its technology and payment infrastructure.
days to go:
Expired
investment:
£2,263,290
niix is a fitness app plugging the gap in the market for women approaching 40. Since its launch in 2018, the company has created a 4+ star rated app with more than 1800 paid subscriptions across 25 countries including the US, Canada, and Australia. It also has an online following of tens of thousands. The global fitness app market is growing fast set to be worth $2 billion by 2023 with a focus on weight loss and body aesthetics for millennial markets. niix sees a huge opportunity in this space to support women who have simply outgrown an approach that want the perfect body and be fit lifelong. With the investment, the company will scale up proven marketing channels to grow community and subscriber bases, making niix the no.1 digital fitness brand for women approaching 40+.
days to go:
Expired
investment:
£153,441
With new MiFID II regulations introduced in January, Hiddensee provides independent investment research mainly on forensic accounting and corporate governance. Analysts will search for inconsistencies and anomalies in the valuation of UK listed mid-cap and smaller companies and publish their reports to assist investors in deciding whether to buy or sell shares.
days to go:
Expired
investment:
£143,097
Autotrip accurately records business mileage taking away the hassle of manually recording a trip. Using a simple plug and play technology users are also able to review the results before submitting the data.
days to go:
Expired
investment:
£121,638
